Navigation Links
Houston Heart Surgeon Elected Vice President of Guatemala
Date:11/5/2007

GUATEMALA CITY, Guatemala, Nov. 5 /PRNewswire/ -- World-renowned heart surgeon Dr. Rafael Espada has made history by becoming the first physician elected Vice President of Guatemala. President-elect Alvaro Colom, with Dr. Espada as his running mate, won yesterday's presidential run-off after earning more than 52.8 percent of the country's votes. The two will take office January 14, 2008.

A native of Guatemala, Dr. Espada has practiced for more than 30 years as a heart surgeon in Houston. He most recently was Deputy Chief of Cardiothoracic Surgery at the Methodist DeBakey Heart Center at The Methodist Hospital.

Dr. Espada's decision to return to Guatemala stems from his continued relationship with the country during his time in the United States. While in Houston, he established Guatemala's first cardiac hospital, Unidad Cardiovascular, which has become the premier heart hospital in Central America.

He also has traveled to Guatemala nearly every month over the last two decades to perform free surgeries for numerous Guatemalan citizens. He routinely has advised Guatemalan officials on a variety of healthcare and economic issues, including successfully mediating a strike between the government and the country's medical professionals.

Dr. Espada says his position of vice president will allow him to build on the economic development and healthcare improvements he has been working on during his time in the United States.

"A great number of Guatemalans are living in poverty, and a great number are sick and dying," says Dr. Espada. "The two problems are not mutually exclusive, and solutions go hand-in-hand. If we can create jobs and spur the economy, more people will be able to afford healthcare."

Dr. Espada's economic development plan involves creating a strong, diversified economy by creating jobs within the country and attracting more international business and investors.

"A safer, better educated country is the key to Guatemala's economic success," says the new Vice President. "We hope to put an end to the violence and corruption that has plagued our country, which will make Guatemala more attractive to foreign business."

To tackle healthcare in Guatemala, Dr. Espada seeks to improve access to preventive medicine and clean drinking water.

"The leading causes of death in Guatemala are not cancer, heart disease, or other similar conditions," the doctor says. "The illnesses killing this country are entirely preventable, and I want to make sure Guatemalans have access to the treatment, medicine and water that can save their lives."

Guatemala also suffers from one of the worst malnutrition rates in the world, affecting more than 50 percent of the country's children. Dr. Espada hopes to gain international support through the United Nations and other health organizations to help combat the problem.

Dr. Espada earned his medical degree at the Universidad San Carlos in Guatemala City, and trained as a heart surgeon under the famed Dr. Michael DeBakey in Houston.

For more information, contact Alan Bentrup at 800-559-4534 (office), 713-553-3358 (mobile) or alan@androvett.com.


'/>"/>
SOURCE Dr. Rafael Espada
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Houston Texans Star Players Ahman Green and Matt Schaub Help Easter Seals, Avondale House and Local Families Tackle Autism
2. Medical Simulation Corporation Announces Partnership with Methodist DeBakey Heart Center in Houston
3. Reliant Energy, Houston Texans Ahman Green and Matt Schaub Team to Hold News Conference, Book Signing to Raise Awareness about Autism
4. Houston Northwest Medical Centers Patient Outcomes Superior
5. Cohen Design Centers Sponsor the AIDS Walks in Los Angeles, Houston, Fort Lauderdale and New York
6. Bayer Foundation Grant Creates Graduate Engineering Fellowship at University of Houston
7. Houston Employers Hear New Research That Supports the Case for Retail Clinics
8. New St. Lukes Medical Clinic Selects Award-Winning globalcentara Provider(SM) by Houstons Global Healthcare Alliance
9. Drug for cluster headaches may cause heart problems
10. Use of certain lipid measures not more effective in predicting coronary heart disease
11. Restricting Blood Flow May Help Heart Bypass Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 2016 , ... A revolution is underway. Brooklyn-based company, ... for the millions of people who require these medical transport services annually. ... the use of technology. Now, SmartEMS has put forth an industry-changing app that ...
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... ... a crisis. Her son James, eight, was out of control. Prone to extreme mood shifts ... upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife ... and say he was going to kill them. If we were driving on the ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016  In a startling report released ... failing their residents by lacking a comprehensive, proven plan to eliminate ... a definitive ranking of how states are tackling the worst drug ... only four states – Kentucky , ... Vermont . Of the 28 failing states, three – ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
(Date:6/23/2016)... , June 23, 2016 , ... on Thursday, July 7, 2016 , , , , LOCATION: ... , , , , EXPERT PANELISTS:  , , , ... Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and ... The global pharmaceutical industry is witnessing an exceptional era. ...
Breaking Medicine Technology: